Atlas Trials

Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD

Clinical trial NCT02590692 · UNKNOWN

Trial details

NCT number
NCT02590692
Sponsor
Regenerative Patch Technologies, LLC
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Dry Macular DegenerationGeographic Atrophy
Start date
2016-02-16
Primary completion
2019-07-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.